about
Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilizationUsing pharmacy data on partial adherence to inform clinical care of patients with serious mental illness.Exploratory data mining analysis identifying subgroups of patients with depression who are at high risk for suicide.Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?Suicide risk assessment received prior to suicide death by Veterans Health Administration patients with a history of depression.Depression, healthcare utilization, and comorbid psychiatric disorders after spinal cord injury.Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts.Who receives outpatient monitoring during high-risk depression treatment periods?Comorbid anxiety as a suicide risk factor among depressed veterans.Examining the relationship between clinical monitoring and suicide risk among patients with depression: matched case-control study and instrumental variable approaches.Antidepressant adherence after psychiatric hospitalization among VA patients with depression.Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use.Predictors of alternative antidepressant agent initiation among U. S. veterans diagnosed with depression.Electroconvulsive therapy for major depression within the Veterans Health Administration.What happened to lithium? Antidepressant augmentation in clinical settings.Treatment of Veterans with depression who died by suicide: timing and quality of care at last Veterans Health Administration visit.Association between opioid prescribing patterns and opioid overdose-related deaths.Risk of mortality among individual antipsychotics in patients with dementiaEfficacy of peer support interventions for depression: a meta-analysis.Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERI.Social relationships and depression: ten-year follow-up from a nationally representative study.Complexity in late-life depression: impact of confounding factors on diagnosis, treatment, and outcomes.Impact of distance and facility of initial diagnosis on depression treatment.Benzodiazepines and adequacy of initial antidepressant treatment for depressionA randomized trial of telephonic counseling plus walking for depressed diabetes patientsUsing a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illnessSuicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort studyPredictors of suicide in patients with dementia.Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression.Emergent anxiety after antidepressant initiation: a retrospective cohort study of Veterans Affairs Health System patients with depression.Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers.Primary care-mental health integration programs in the veterans affairs health system serve a different patient population than specialty mental health clinicsPatient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system.Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment.Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depressionStudent and Nonstudent National Guard Service Members/Veterans and Their Use of Services for Mental Health Symptoms.Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.Cost savings from assertive community treatment services in an era of declining psychiatric inpatient useDifferential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
P50
Q30714937-9AA2816E-2538-494B-A3BD-BE9BC7E69B12Q30871055-A04BE03E-B12C-49FC-A043-33BE32CFAFE5Q33286118-51B98961-0CA0-4D18-BA13-B9C73BB0E4E1Q33520571-0C477F37-0F7F-4933-BB00-52BC41A89CDEQ33707663-A0A39B30-3F28-4B76-B49C-4DAAFED53380Q33746681-9BC9562B-026D-402E-9F8D-1C61D99374E7Q33790289-CEC04F0C-08E4-47F8-A79B-FA6727827BEAQ34017861-CA09250A-37C7-4E10-83E7-3D61A4E8DFFBQ34083835-E7F1493E-CF53-43C3-9BC8-80664DDBA8ACQ34111089-40384D53-7A1E-4654-ACA8-B1B5522E0F7DQ34126937-DC59AD5A-64D4-45A4-85DE-D1E45D2B87AEQ34135716-E68730CF-EF96-45B3-9E20-72B324E91C65Q34136378-66E8B97B-C081-4827-B4AC-47CC44B86B27Q34166761-EAC7B59E-5BBD-46CE-86BD-DCB5DECB79DBQ34490228-50F119A9-1572-491D-89EA-0E37455D9746Q34543983-E20CD7AC-01BB-4D08-B4C2-448D3C3D3C4CQ34577110-FAFC9AE8-9955-4AEE-9972-138BFB8B5D3DQ34628224-C72A7710-02AD-4F62-8AD6-D0255D860735Q34634590-D5E9E32D-3424-48A6-96FF-44DE4A6D9358Q34644729-0EC65970-D867-4E9F-9AAC-D1140952EA7AQ34680925-0FCAED27-5637-4793-A1EC-ADD7CAB8200FQ34706777-7739F90A-97FC-4CCA-858A-AE7EC00D1CF7Q34851711-08689638-8F48-4DA7-B7AB-E77AF162F53FQ34990773-5D8CB7B4-C1ED-41BC-AF85-3DFACA1A5992Q35005307-59AD55AD-F21C-4948-8F08-E6133EDDCBE8Q35053515-30BE65F5-D0A1-4620-BE78-49C797A7CBBDQ35065381-A4A6065F-989D-4DAF-9891-57A7E3A383D4Q35129198-9E737ACA-3FA0-47B0-8454-5C0218D5EDCFQ35534414-ABFB64BF-6273-49CA-ADAF-DAA246BABCC4Q35684304-9553AB66-F727-4574-9861-6A6B4670CC24Q35841410-4E643A7C-6A5F-42EB-A9A0-C62CEA314787Q35954972-A05C5E6D-CECC-4B1B-806B-5EB6610BA22EQ36302837-1BF26F4A-B166-4DE2-BAE4-9D9167B29117Q36363557-8D479937-F516-4A63-818D-B4CD3CEE3D50Q36454588-F396C533-5FB1-4166-88DA-14CADE832F9DQ36552261-241BCBC7-921B-4E08-B039-AFD575A2ACACQ36645898-2D6C8252-ABBF-4B0D-9FAE-E627D88BBDABQ36654304-4F3BD52B-B5C2-4239-B913-EAAE0747532BQ36661494-52EDFC95-D0A6-4AD8-8014-4D1588A41830Q36730924-6BB82905-C2E2-49D7-90D6-65A97628783B
P50
name
Marcia Valenstein
@en
Marcia Valenstein
@nl
type
label
Marcia Valenstein
@en
Marcia Valenstein
@nl
prefLabel
Marcia Valenstein
@en
Marcia Valenstein
@nl